These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 25684498)

  • 1. Parecoxib: an enhancer of radiation therapy for colorectal cancer.
    Xiong W; Li WH; Jiang YX; Liu S; Ai YQ; Liu R; Chang L; Zhang M; Wang XL; Bai H; Wang H; Zheng R; Tan J
    Asian Pac J Cancer Prev; 2015; 16(2):627-33. PubMed ID: 25684498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo evaluation of the radiosensitizing effect of a selective FGFR inhibitor (JNJ-42756493) for rectal cancer.
    Verstraete M; Debucquoy A; Gonnissen A; Dok R; Isebaert S; Devos E; McBride W; Haustermans K
    BMC Cancer; 2015 Dec; 15():946. PubMed ID: 26675289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Icotinib hydrochloride enhances the effect of radiotherapy by affecting DNA repair in colorectal cancer cells.
    Ma H; Bi J; Liu T; Ke Y; Zhang S; Zhang T
    Oncol Rep; 2015 Mar; 33(3):1161-70. PubMed ID: 25572529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin sensitizes human colorectal cancer xenografts in nude mice to gamma-radiation by targeting nuclear factor-kappaB-regulated gene products.
    Kunnumakkara AB; Diagaradjane P; Guha S; Deorukhkar A; Shentu S; Aggarwal BB; Krishnan S
    Clin Cancer Res; 2008 Apr; 14(7):2128-36. PubMed ID: 18381954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclooxygenase inhibitors decrease the growth and induce regression of human esophageal adenocarcinoma xenografts in nude mice.
    Santander S; Cebrián C; Esquivias P; Conde B; Esteva F; Jiménez P; Ortego J; Lanas A; Piazuelo E
    Int J Oncol; 2012 Feb; 40(2):527-34. PubMed ID: 21971589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2.
    Pyo H; Choy H; Amorino GP; Kim JS; Cao Q; Hercules SK; DuBois RN
    Clin Cancer Res; 2001 Oct; 7(10):2998-3005. PubMed ID: 11595687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of intrinsic tumor cell radiosensitivity induced by a selective cyclooxygenase-2 inhibitor.
    Petersen C; Petersen S; Milas L; Lang FF; Tofilon PJ
    Clin Cancer Res; 2000 Jun; 6(6):2513-20. PubMed ID: 10873107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The small molecule AU14022 promotes colorectal cancer cell death via p53-mediated G2/M-phase arrest and mitochondria-mediated apoptosis.
    Ryu H; Nam KY; Kim JS; Hwang SG; Song JY; Ahn J
    J Cell Physiol; 2018 Jun; 233(6):4666-4676. PubMed ID: 29030986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol elicits anti-colorectal cancer effect by activating miR-34c-KITLG in vitro and in vivo.
    Yang S; Li W; Sun H; Wu B; Ji F; Sun T; Chang H; Shen P; Wang Y; Zhou D
    BMC Cancer; 2015 Dec; 15():969. PubMed ID: 26674205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiosensitization by irinotecan is attributed to G2/M phase arrest, followed by enhanced apoptosis, probably through the ATM/Chk/Cdc25C/Cdc2 pathway in p53-mutant colorectal cancer cells.
    Wang Y; Yang L; Zhang J; Zhou M; Shen L; Deng W; Liang L; Hu R; Yang W; Yao Y; Zhang H; Zhang Z
    Int J Oncol; 2018 Oct; 53(4):1667-1680. PubMed ID: 30085332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiosensitizer Effect of β-Apopicropodophyllin against Colorectal Cancer via Induction of Reactive Oxygen Species and Apoptosis.
    Kwon JH; Lee NG; Kang AR; Song JY; Hwang SG; Um HD; Kim J; Park JK
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anginex synergizes with radiation therapy to inhibit tumor growth by radiosensitizing endothelial cells.
    Dings RP; Williams BW; Song CW; Griffioen AW; Mayo KH; Griffin RJ
    Int J Cancer; 2005 Jun; 115(2):312-9. PubMed ID: 15688384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crizotinib Fails to Enhance the Effect of Radiation in Head and Neck Squamous Cell Carcinoma Xenografts.
    Baschnagel AM; Galoforo S; Thibodeau BJ; Ahmed S; Nirmal S; Akervall J; Wilson GD
    Anticancer Res; 2015 Nov; 35(11):5973-82. PubMed ID: 26504020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sorafenib sensitizes human colorectal carcinoma to radiation via suppression of NF-κB expression in vitro and in vivo.
    Kuo YC; Lin WC; Chiang IT; Chang YF; Chen CW; Su SH; Chen CL; Hwang JJ
    Biomed Pharmacother; 2012 Feb; 66(1):12-20. PubMed ID: 22265104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elucidating the mechanisms of action of parecoxib in the MG-63 osteosarcoma cell line.
    Lemos S; Sampaio-Marques B; Ludovico P; Gaivão I; Palmeira C; Martins G; Peixoto F; Pinto-Leite R; Oliveira P
    Anticancer Drugs; 2020 Jun; 31(5):507-517. PubMed ID: 31934887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patrinia scabiosaefolia inhibits colorectal cancer growth through suppression of tumor angiogenesis.
    Chen L; Liu L; Ye L; Shen A; Chen Y; Sferra TJ; Peng J
    Oncol Rep; 2013 Sep; 30(3):1439-43. PubMed ID: 23820929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulating Survivin as a Radioresistant Factor, Caspase-3, and Apoptosis by Omega-3 Docosahexaenoic Acid Sensitizes Mutant-p53 Colorectal Cancer Cells to γ-Irradiation.
    Hosseini F; Sam MR; Jabbari N; Mozdarani H
    Cancer Biother Radiopharm; 2018 Nov; 33(9):387-395. PubMed ID: 30395490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parecoxib Enhances Resveratrol against Human Colorectal Cancer Cells through Akt and TXNDC5 Inhibition and MAPK Regulation.
    Chang WL; Yang KC; Peng JY; Hong CL; Li PC; Chye SM; Lu FJ; Shih CW; Chen CH
    Nutrients; 2024 Sep; 16(17):. PubMed ID: 39275334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of M2 macrophage autophagy by rapamycin increases the radiosensitivity of colorectal cancer xenografts.
    Shao L; Wu Y; Cao J; Zhong F; Yang X; Xing C
    J Cancer Res Ther; 2024 Apr; 20(2):695-705. PubMed ID: 38687942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of PHA-665752 and Cetuximab Combination Treatment on In Vitro and Murine Xenograft Growth of Human Colorectal Cancer Cells with KRAS or BRAF Mutations.
    Jia YT; Yang DH; Zhao Z; Bi XH; Han WH; Feng B; Zhi J; Gu B; Duan Z; Wu JH; Ju YC; Wang MX; Li ZX
    Curr Cancer Drug Targets; 2018; 18(3):278-286. PubMed ID: 28359236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.